Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ALTEPLASE
- Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5
- ALteplase in Patients With LOW NIHSS and Specified Disabling Deficits
- A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Stroke Patients Undergoing EndoVascular Treatment (EVT)
- Predictors of AIS Unfavorable Outcomes
- Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke
- PLEURAL IRRIGATION WITH NORMAL SALINE VERSUS INTRAPLEURAL FIBRINOLYTIC IN PLEURAL INFECTION
- Endovascular Stroke Treatment And Reteplase Protocol
- Intra-arterial Thrombolysis After Successful Thrombectomy for Acute Ischemic Stroke in the Posterior Circulation (IAT-TOP)
- Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy
- Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion
- Comparison of Outcomes Between Low and Standard Dose Intrapleural tPA for Pleural Infection
- Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）
- Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke
- Intravenous Tenecteplase and Mechanical Thrombectomy Techniques on 4.5 to 24 Hours After Basilar Artery Occlusion
- rhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)
- Trial of Intra-arterial Tenecteplase Following Successful Endovascular Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke
- Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window
- Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke
- Tenecteplase Compared to Alteplase for Patients With Large Vesel Oclusion Suspicion Before Thrombectomy
- Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke
- Additive Effects of Intra-arterial Tenecteplase for Successful Thrombectomy Due to Acute Basilar Artery Occlusion
- Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure
- Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism
- Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic
- Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With Acute Limb Ischemia FORAT Trial
- A Study of r-PA Treating Patients With Acute Ischemic Stroke
- Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II）
- TPA in Acute Stroke With COVID Verus Non-COVID-19 Patients
- A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke
- Inhaled Recombinant Non-immunogenic Staphylokinase vs Placebo in Patients With COVID-19 - FORRIF Trial
- Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke
- Adaptive Efficacy and Safety Study of Glenzocimab Used as an add-on Therapy on Top of Standard of Care un the 4.5 Hours Following an Acute Ischemic Stroke
- Early Reperfusion Therapy With Intravenous Alteplase for Recovery of VISION in Acute Central Retinal Artery Occlusion
- In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection
- N-ACETYLCYSTEINE FOR THROMBOLYSIS IN ACUTE STROKE
- A Study in Chinese Patients to Compare How Tenecteplase and Alteplase Given After a Stroke Improve Recovering of Physical Activity
- Short Duration High Intensity Intrapleural Alteplase With Pulmozyme in Pleural Infection Management
- Combination of the Immune Modulator Dimethyl Fumarate With Alteplase in Acute Ischemic Stroke
- 24 Hours Treatment With Alteplase in Patients With Ischemic Stroke
- Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅱ
- MRI-guided thrOmbolysis for Stroke bEyond Time Window by TNK
- Endovascular Treatment With Versus Without Intravenous Tenecteplase in Stroke
- Recombinant Non-immunogenic Staphylokinase VS Alteplase for Massive PE a Randomized Non-inferiority Trial
- Combinating Fingolimod With Alteplase Bridging With Thrombectomy in Acute Ischemic Stroke
- A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19
- Fingolimod in Endovascular Treatment of Ischemic Stroke
- Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs)
- INtravenous TNK for Acute isChemicsTroke in China
- Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis
- Extending the Time Window for Tenecteplase by Effective Reperfusion in Patients With Large Vessel Occlusion
- Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19)
- Pulmonary Embolism International THrOmbolysis Study-3
- A Study in Healthy Men to Compare 2 Different Formulations of Alteplase
- Endovascular Acute Stroke Intervention - Tandem OCclusion Trial
- Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke
- Boosting REcanalization of Thrombectomy for Ischemic Stroke by Intra-arterial TNK (BRETIS-TNK)
- Improving Neuroprotective Strategy for Ischemic Stroke With Poor Recanalization After Thrombectomy by Intra-arterial TNK (INSIST-TNK)
- Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism
- Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance
- Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism
- Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke
- Intraarterial Alteplase Versus Placebo After Mechanical Thrombectomy
- Management of Pleural Space Infections
- The Norwegian Tenecteplase Stroke Trial 2
- Low Dose Catheter Directed Thrombolysis for Acute Pulmonary Embolism
- Low-dose Versus Standard Dose Alteplase in Acute Ischemic Stroke , 4 Monthes Prospective Study
- Ginkgolide With Intravenous Alteplase Thrombolysis in Acute Ischemic Stroke Neurological Improving Trial
- Intramyocardial Haemorrhage in Patients With Primary STEMI
- Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke
- Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality
- Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE
- Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)
- Direct Intra-arterial Thrombectomy in Order to Revascularize AIS Patients With Large Vessel Occlusion Efficiently in Chinese Tertiary Hospitals
- Tirofiban for Patients Treated With Alteplase
- Study of Sodium Bicarbonate in Restoring Blocked Catheters
- Intracranial Collaterals in Acute Stroke and Clinical Outcome
- Role of Anti-platelet in Treatment of Acute Ischemic Stroke
- A Phase III Randomized, Blind, Double Dummy, Multicenter Study Assessing the Efficacy and Safety of IV THrombolysis (Alteplase) in Patients With acutE Central retInal Artery Occlusion
- Tenecteplase in Wake-up Ischaemic Stroke Trial
- Single Bolus Recombinant Nonimmunogenic Staphylokinase (Fortelyzin) and Bolus Infusion Alteplase in Patients With AIS
- A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism
- Inhaled Nitric Oxide After Out-of-Hospital Cardiac Arrest
- Combinating Fingolimod With Alteplase Bridging With Mechanical Thrombectomy in Acute Ischemic Stroke
- Safety and Efficacy of Alteplase When Administered in Chinese Patients With Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4.5 Hours After Stroke Onset
- Early Administration of Aspirin in Patients With Acute Ischemic Stroke Treated With Systemic Thrombolysis
- Optimal Coronary Flow After PCI for Myocardial Infarction - a Pilot Study
- Intravenous Thrombolysis Registry for Chinese Ischemic Stroke Within 4.5 h Onset
- The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI
- Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis
- Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial
- Basilar Artery Occlusion Chinese Endovascular Trial
- Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism
- XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis
- Intensive Versus Standard Hemodialysis CVC Dysfunction Protocol
- Quality of Life After Stroke Using a Telemedicine-based Stroke Network
- Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke
- Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis
- Perfusion Computer Tomography: Imaging and Clinical Validation Following Reperfusion Therapy in Acute Ischaemic Stroke
- A Trial of Low-dose Adjunctive alTeplase During prIMary PCI
- A Study of Pre-hospital Treatment of Acute Myocardial Infarction Based on Diagnosis by Interpretation of Remotely Acquired ECG and Thrombolysis With Accelerated Alteplase ( Actilyse®)
- An International Observational Study of the Safety and Efficacy of Thrombolysis in Stroke
- Safe Implementation of Thrombolysis in Stroke - Monitoring Study
- Trial to Compare 1.0 Versus 2.0 mg Alteplase (tPA) Dosing in Restoring Hemodialysis Catheter Function
- Embolectomy in Acute SYlvian Thrombosis in Refractory or Ineligible Patients to ALteplase
- A Study to Investigate the Procoagulant Effect of Tenecteplase (TNK-tPA), Alteplase (Rt-PA) and Streptokinase (SK) Administered to Patients With Acute Myocardial Infarction (AMI)
- Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)
- A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke
- Thrombectomy Under Reopro Versus Alteplase to Treat Stoke
- THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)
- Comparison of Low-Molecular-Weight Heparin (LMWH) and Unfractionated Heparin (UFH) in Combination With Thrombolytic Treatment of Acute Massive Pulmonary Thromboembolism
- Study of Tenecteplase Versus Alteplase for Thrombolysis (Clot Dissolving) in Acute Ischemic Stroke
- EARLY Routine Catheterization After Alteplase Fibrinolysis vs. PPCI in ST-Segment-Elevation MYOcardial Infarction
- Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage
- Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD
- Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III
- Pragmatic Ischaemic Stroke Thrombectomy Evaluation
- Prolonged Hemodialysis Catheter Survival With Copolymer Coating and Rt-PA
- Safety of Intravenous Thrombolytics in Stroke on Awakening
- Efficacy and Safety of MRI-based Thrombolysis in Wake-up Stroke
- Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy
- Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)
- Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention
- A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
- Efficacy and Security of Intrapleurally Alteplase vs Urokinase for the Treatment of Complicated Parapneumonic Effusion and Empyema
- Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis
- Enhancing Donated After Cardiac Death (DCD) Utilization With Thrombolytic Therapy
- Safety of Intravenous Thrombolysis for Wake-up Stroke
- Study for the Use of Alteplase in Patients Who Awaken With Stroke
- Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke
- Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)
- Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke
- Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke
- Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
- Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
- Safety Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke
- Desmoteplase in Acute Ischemic Stroke (DIAS)
- Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS)
- IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion
- Efficacy and Safety of Activase (Ateplase) vs Placebo in Complicated Pleural Effusions (CPE)/Empyemas
- Study of Aspirin and TPA in Acute Ischemic Stroke
- Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ）
- Cathflo Activase Pediatric Study
- Alteplase for Blood Flow Restoration in Hemodialysis Catheters
- Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses
- Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants
- Microbubbles and Ultrasound in Stroke Trial: MUST Study
- Rt-PA in the Treatment of Acute Ischemic Stroke
- Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial Infarction
- Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke
- FRALYSE Trial: Comparison of the Classical Rt-PA Procedure With a Longer Procedure in Acute Ischemic Stroke
- Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion
- Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins
- OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial Infarction
- Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)
- A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)
- Myocardial Infarction Triage and Intervention Project (MITI)
Clinical trials list
click for details